Information materials on mammography screening in Austria - Do they help women with informed decision?;Informationsmaterialien zum Mammographiescreening in Österreich - Unterstützen sie die informierte Entscheidung von Frauen?

Sozial- und Praventivmedizin

Volumn 49, Issue 6, 2004, Pages 391-397

  Rásky, Éva ^a   Groth, Sylvia ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b Fraeungesundheitszentrum   (Austria)

Author keywords

Information; Informed decision; Pamphlets; Screening mammography

Indexed keywords

ARTICLE; AUSTRIA; CONSUMER; CONTROLLED STUDY; HEALTH CARE; HUMAN; INFORMATION DISSEMINATION; INFORMED CONSENT; MAMMOGRAPHY; MEDICAL DECISION MAKING; PATIENT RIGHT; PREVENTION; SCIENTIFIC LITERATURE; SCREENING TEST; ADULT; AGED; ATTITUDE TO HEALTH; BREAST TUMOR; FEMALE; MASS SCREENING; MIDDLE AGED; PATIENT EDUCATION; PUBLICATION;

ADULT; AGED; AUSTRIA; BREAST NEOPLASMS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMED CONSENT; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PAMPHLETS; PATIENT EDUCATION;

EID: 13444293200     PISSN: 03038408     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00038-004-3092-0     Document Type: Article

References (25)

1. ACO/Arbeitsgemeinschaft für Chirurgische Onkologie der Österreichischen Gesellschaft für Chirurgie (1993). Konsensus Bericht Mammakarzinom. Wien: ACO.
2. Black WC, Nease RF, Tosteson ANA (1995). Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Nat Cancer Institute 87: 720-31.
3. Chamot E, Perneger TV (2001). Misconceptions about efficacy of mammography screening: A public health dilemma. J Epidemiol Community Health 55: 799-803.
4. Coulter A, Entwistle V, Gilbert D (1998). Informing patients: An assessment of the quality of patient information materials. London: King's Fund.
5. Coulter A, Entwistle V, Gilbert D (1999). Sharing decisions with patients: Is the information good enough? BMJ 318: 318-22.
6. Curry SJ, Taplin SH, Anderman C, Barlow WE, McBride C (1993). A randomised trial of the impact of risk assessment and feedback on participation in mammographic screening. Prev Med 22: 350-60.
7. Ernster VL (1997). Mammographic screening for women aged 40 through 49: a guidelines saga and a clarion call for informed decision making. Am J Publ Health 7: 1103-6.
8. Fletcher SW (1997). Whither scientific deliberation in health policy recommendations? - Alice in the wonderland of breast cancer screening. New Engl J Med 336: 1180-3.
9. Forrow L, Taylor, WC, Arnols RM (1992). Absolutely relative: How research results are summarized can affect treatment decisions. Am J Med 92: 121-4.
10. General Medical Council (1999). Protecting patients, guiding doctors. Seeking patients' consent: The ethical considerations. London: GMC.
11. Gesellschaft für Strahlenschutz e.V. (2001). Brustkrebsfrüherkennenung Ja, Reihenuntersuchung mit Mammographie Nein! Bericht 23: 1-38.
12. Hoffrage U, Gigerenzer G (1998). Using natural frequencies to improve diagnostic inferences. Academic Medicine 73: 538-40.
13. Hoffrage U, Lindsay S, Hertwig R, Gigerenzer G (2000). Communicating statistical information. Science 290: 2261-2.
14. Humphrey LL, Helfand M, Chan BKS, Woolf SH (2002). Breast cancer screening: A summary of the evidence for the U.S. Preventive Task Force. Ann Intern Med 137: 347-60.
15. Kavanagh AM, Mitchell H, Giles GG (2000). Hormone replacement therapy and accuracy of mammographic screening. Lancet 355: 270-4.
16. Kurzenhäuser S (2003). Welche Informationen vermitteln deutsche Gesundheitsbroschüren über die Screening-Mammographie? Z Ärztl Fortbild Qualitätssich 97: 53-7.
17. Miller AB, To T, Baines CJ, Wall C (2002). The Canadian national breast screening study-1: Breast cancer mortality after 11 to 16 years of follow-up: A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 137: 305-12.
18. Mühlhauser I, Höldke B (1999). Mammographie- Screening Darstellung der wissenschaftlichen Evidenz-Grundlage zur Kommunikation mit der Frau. arzneitelegramm 10: 101-8.
19. O'Sullivan I, Sutton S, Dixon S, Perry N (2001). False positive results do not have a negative effect on re-attendance for subsequent breast screening. J Med Screen 8: 145-8.
20. Olsen O, Goetzsche PC (2002). Screening for breast cancer with mammography (Cochrane Review). Oxford: Update Software: The Cochrane Library, Issue 4.
21. Perry N, Broeders M, de Wolf C, Törnberg S (2001). European guidelines for quality assurance in mammography screening. Luxembourg: European Commission.
22. Rigby M, Forsström J, Roberts R, Wyatt J, for the TEAC-Health Partners (2001). Verifying quality and safety in health informatics services. BMJ 323: 552-6.
23. Schwartz LM, Woloshin S, Cox HC, Fischhoff B, Welch HG (2000). US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: Cross sectional survey. BMJ 320: 1635-40.
24. Slaytor EK, Ward JE (1998). How risk of breast cancer and benefits of screening are communicated to women: Analysis of 58 pamphlets. BMJ 317: 263-4.
25. Wild C (2001). Screening in Austria. Int J Technol Assess Health Care 17: 305-15.